Skip to main content
Erschienen in: European Radiology 5/2019

13.12.2018 | Gastrointestinal

Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobes

verfasst von: Soudabeh Fazeli Dehkordy, Kathryn J. Fowler, Adrija Mamidipalli, Tanya Wolfson, Cheng William Hong, Yesenia Covarrubias, Jonathan C. Hooker, Ethan Z. Sy, Alexandra N. Schlein, Jennifer Y. Cui, Anthony C. Gamst, Gavin Hamilton, Scott B. Reeder, Claude B. Sirlin

Erschienen in: European Radiology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The purpose of this study was to (1) evaluate proton density fat fraction (PDFF) distribution across liver segments at baseline and (2) compare longitudinal segmental PDFF changes across time points in adult patients undergoing a very low-calorie diet (VLCD) and subsequent bariatric weight loss surgery (WLS).

Methods

We performed a secondary analysis of data from 118 morbidly obese adult patients enrolled in a VLCD-WLS program. PDFF was estimated using magnitude-based confounder-corrected chemical-shift-encoded (CSE) MRI in each hepatic segment and lobe at baseline (visit 1), after completion of VLCD (visit 2), and at 1, 3, and 6 months (visits 3–5) following WLS. Linear regressions were used to estimate the rate of PDFF change across visits. Lobar and segmental rates of change were compared pairwise.

Results

Baseline PDFF was significantly higher in the right lobe compared to the left lobe (p < 0.0001). Lobar and segmental PDFF declined by 3.9–4.5% per month between visits 1 and 2 (preoperative period) and by 4.3–4.8% per month between visits 1 and 3 (perioperative period), but no significant pairwise differences were found in slope between segments and lobes. For visits 3–5 (postoperative period), lobar and segmental PDFF reduction was much less overall (0.4–0.8% PDFF per month) and several pairwise differences were significant; in each case, a right-lobe segment had greater decline than a left-lobe segment.

Conclusions

Baseline and longitudinal changes in fractional fat content in the 5-month postoperative period following WLS vary across segments, with right-lobe segments having higher PDFF at baseline and more rapid reduction in liver fat content.

Key Points

• Baseline and longitudinal changes in liver fat following bariatric weight loss surgery vary across liver segments.
• Methods that do not provide whole liver fat assessment, such as liver biopsy, may be unreliable in monitoring longitudinal changes in liver fat following weight loss interventions.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10:686–690CrossRefPubMed Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10:686–690CrossRefPubMed
2.
Zurück zum Zitat Eguchi Y, Hyogo H, Ono M et al (2012) Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 47:586–595CrossRefPubMed Eguchi Y, Hyogo H, Ono M et al (2012) Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 47:586–595CrossRefPubMed
3.
Zurück zum Zitat Lazo M, Clark JM (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28:339–350CrossRefPubMed Lazo M, Clark JM (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28:339–350CrossRefPubMed
4.
Zurück zum Zitat Hannah WN Jr, Torres DM, Harrison SA (2016) Nonalcoholic steatohepatitis and endpoints in clinical trials. Gastroenterol Hepatol (N Y) 12:756–763 Hannah WN Jr, Torres DM, Harrison SA (2016) Nonalcoholic steatohepatitis and endpoints in clinical trials. Gastroenterol Hepatol (N Y) 12:756–763
5.
Zurück zum Zitat Younossi ZM, Stepanova M, Afendy M et al (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9:524–530.e1CrossRefPubMed Younossi ZM, Stepanova M, Afendy M et al (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9:524–530.e1CrossRefPubMed
6.
Zurück zum Zitat Torres DM, Harrison SA (2008) Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 134:1682–1698CrossRefPubMed Torres DM, Harrison SA (2008) Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 134:1682–1698CrossRefPubMed
7.
Zurück zum Zitat Dixon JB, Bhathal PS, Hughes NR, O’Brien PE (2004) Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39:1647–1654CrossRefPubMed Dixon JB, Bhathal PS, Hughes NR, O’Brien PE (2004) Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39:1647–1654CrossRefPubMed
8.
Zurück zum Zitat Tang A, Tan J, Sun M et al (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422CrossRefPubMedPubMedCentral Tang A, Tan J, Sun M et al (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Middleton MS, Heba ER, Hooker CA et al (2017) Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 153:753–761CrossRefPubMed Middleton MS, Heba ER, Hooker CA et al (2017) Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 153:753–761CrossRefPubMed
10.
Zurück zum Zitat Le TA, Chen J, Changchien C et al (2012) Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 56:922–932CrossRefPubMed Le TA, Chen J, Changchien C et al (2012) Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 56:922–932CrossRefPubMed
11.
Zurück zum Zitat Bonekamp S, Tang A, Mashhood A et al (2014) Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging 39:1525–1532CrossRefPubMedPubMedCentral Bonekamp S, Tang A, Mashhood A et al (2014) Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging 39:1525–1532CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Sofue K, Mileto A, Dale BM, Zhong X, Bashir MR (2015) Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm. J Magn Reson Imaging 42:1281–1290 Sofue K, Mileto A, Dale BM, Zhong X, Bashir MR (2015) Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm. J Magn Reson Imaging 42:1281–1290
13.
Zurück zum Zitat Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:spconeCrossRef Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:spconeCrossRef
14.
Zurück zum Zitat Reeder SB, Hu HH, Sirlin CB (2012) Proton density fat-fraction: a standardized mr-based biomarker of tissue fat concentration. J Magn Reson Imaging 36:1011–1014CrossRefPubMedPubMedCentral Reeder SB, Hu HH, Sirlin CB (2012) Proton density fat-fraction: a standardized mr-based biomarker of tissue fat concentration. J Magn Reson Imaging 36:1011–1014CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Bydder M, Yokoo T, Hamilton G et al (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26:347–359CrossRefPubMedPubMedCentral Bydder M, Yokoo T, Hamilton G et al (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26:347–359CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Hamilton G, Yokoo T, Bydder M et al (2011) In vivo characterization of the liver fat 1H MR spectrum. NMR Biomed 24:784–790CrossRefPubMed Hamilton G, Yokoo T, Bydder M et al (2011) In vivo characterization of the liver fat 1H MR spectrum. NMR Biomed 24:784–790CrossRefPubMed
17.
Zurück zum Zitat Yokoo T, Serai SD, Pirasteh A et al (2018) Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology 286:486–498CrossRefPubMed Yokoo T, Serai SD, Pirasteh A et al (2018) Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology 286:486–498CrossRefPubMed
18.
Zurück zum Zitat Copher GH, Dick BM (1928) “Stream line” phenomena in the portal vein and the selective distribution of portal blood in the liver. Arch Surg 17:408–419CrossRef Copher GH, Dick BM (1928) “Stream line” phenomena in the portal vein and the selective distribution of portal blood in the liver. Arch Surg 17:408–419CrossRef
19.
Zurück zum Zitat Fuchs HF, Broderick RC, Harnsberger CR et al (2015) Benefits of bariatric surgery do not reach obese men. J Laparoendosc Adv Surg Tech A 25:196–201CrossRefPubMed Fuchs HF, Broderick RC, Harnsberger CR et al (2015) Benefits of bariatric surgery do not reach obese men. J Laparoendosc Adv Surg Tech A 25:196–201CrossRefPubMed
Metadaten
Titel
Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobes
verfasst von
Soudabeh Fazeli Dehkordy
Kathryn J. Fowler
Adrija Mamidipalli
Tanya Wolfson
Cheng William Hong
Yesenia Covarrubias
Jonathan C. Hooker
Ethan Z. Sy
Alexandra N. Schlein
Jennifer Y. Cui
Anthony C. Gamst
Gavin Hamilton
Scott B. Reeder
Claude B. Sirlin
Publikationsdatum
13.12.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5894-0

Weitere Artikel der Ausgabe 5/2019

European Radiology 5/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.